Compounds > amikacin
Page last updated: 2024-08-23

amikacin and Acinetobacter Infections

amikacin has been researched along with Acinetobacter Infections in 75 studies

*Acinetobacter Infections: Infections with bacteria of the genus ACINETOBACTER. [MeSH]

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19904 (5.33)18.7374
1990's7 (9.33)18.2507
2000's27 (36.00)29.6817
2010's30 (40.00)24.3611
2020's7 (9.33)2.80

Authors

AuthorsStudies
Fulcher, LC; Griffith, ME; Hawley, JS; Hospenthal, DR; Jorgensen, JH; McElmeel, ML; Murray, CK1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A1
Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM1
Adams, JM; Doi, Y; Paterson, DL; Yamane, K1
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y1
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J1
Bratu, S; Georgescu, C; Landman, D; Martin, DA; Quale, J1
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R1
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE1
Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P1
Aquino, EE; León, CF; Otero, DM; Robledo, IE; Santana, JL; Santé, MI; Vázquez, GJ1
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH1
Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Gebrecherkos, T; Mekonnen, H; Molla Fenta, G; Seid, A1
Gunawan, C; Hamidian, M; Harmer, CJ; Mann, R; Rafei, R1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X1
Alves, LC; Bezerra Cavalcanti, CL; Brayner, FA; da Silva, EM; de Araújo, AR; de Freitas, CF; de Lima, FCG; do Nascimento, AV; Oliveira Júnior, JB; Sandes, JM; Veras, DL1
Aris, P; Boroumand, MA; Douraghi, M1
Pillay, M; Swe Swe-Han, K1
Alaghehbandan, R; Alinejad, F; Azimi, L; Lari, AR; Tahbaz, SV1
Alves, LC; Brayner, FA; Cavalcanti, CLB; da Rocha, DAM; da Silva, EM; Freitas, CF; Lima, FCG; Oliveira-Júnior, JB; Sandes, JM; Veras, DL1
Hakamifard, A; Naji Esfahani, SS; Shafiee, F; Soltani, R1
Arnaud, E; Larcher, R; Lavigne, JP; Pantel, A; Sotto, A1
Chatsuwan, T; Singkham-In, U1
Chan, TF; Ip, M; Lau, TC; Lin, X; Lo, NW; Loo, J; Qin, H; Tsui, SK; Yim, AK1
Javadi, A; Kazemian, H; Kodori, M; Monfared, MRZ; Rad, MR; Rahdar, H; Yazdani, F1
Chung, ES; Ko, KS1
Bošković, L; Božić, DD; Ivković, B; Milenković, M; Ušjak, D1
Chiem, K; Jimenez, V; Magallon, J; Ramirez, MS; Tolmasky, ME; Tran, T1
Abou El-Khier, NT; Rizk, MA1
Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S1
Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L1
Lanao, JM; Martín-Suárez, A; Zazo, H1
Alcántar-Curiel, MD; Alpuche-Aranda, CM; Araiza-Navarro, JR; Esparza-Ahumada, S; Flores-Vaca, M; Gayosso-Vázquez, C; González-Díaz, E; Morfín-Otero, R; Pérez-Gómez, HR; Rocha, MJ; Rodríguez-Noriega, E; Santos-Preciado, JI1
Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ1
Hall, RM; Nigro, SJ1
Hall, RM; Holt, KE; Nigro, SJ; Pickard, D1
Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F1
Culebras, E; García-Salguero, C; Picazo, JJ; Rodríguez-Avial, I1
Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M1
Asai, S; Inokuchi, S; Iwashita, H; Kaneko, A; Miyachi, H; Ohashi, M; Ohshima, T; Sasaki, M; Umezawa, K1
Ahangarzadeh Rezaee, M; Ghotaslou, R; Goli, HR; Hasani, A; Rahmati-Yamchi, M; Sheikhalizadeh, V1
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR1
Barrou, L; Benslama, A; Charra, B; Hachimi, A; Idali, B; Motaouakkil, S1
Chong, Y; Hong, HL; Jeong, SH; Kang, JO; Kim, JS; Kim, MN; Lee, K; Park, YJ; Shin, JH; Yong, D1
Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY1
Amudhan, MS; Balaraman, S; Kamalanathan, A; Sekar, U1
Chankova, D; Dinev, N; Savov, E; Vatcheva, R1
Dhingra, VK; Gorman, SK; Ronco, JJ; Zed, PJ1
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A1
Benomar, S; Bouharrou, A; Habzi, A; Lahbabi, M; Najdi, T; Nejjari, N; Zerhouni, F1
Adamidou, M; Bacopoulou, F; Markantonis, SL; Pavlou, E1
Arakawa, Y; Doi, Y; Kato, H; Shibata, N; Shibayama, K; Wachino, J; Yagi, T; Yamane, K1
Bernabeu-Wittel, M; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C1
Fulnecky, EJ; Kanawati, L; Scheld, WM; Shoham, S; Wright, D1
Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D1
Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH1
Benslama, A; Charra, B; Hachimi, A; Motaouakkil, S1
Bannan, CL; Boutlis, CS; Chih, DT; Elston, JW1
Chang, KT; Hou, JG; Kwa, AL; Ledesma, KR; Lim, TP; Nikolaou, M; Prince, RA; Quinn, JP; Tam, VH1
Akin, ES; Bilgiç, H; Ekiz, K; Seber, O; Taşan, Y1
Harris, SP; Muder, RR; Nguyen, MH; Pasculle, AW1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R1
Alamo, I; Ballester, F; Becerril, B; de Anta, TJ; Garcia, I; Lopez-Hernandez, I; Martinez-Beltran, J; Navia, M; Perea, S; Planes, AM; Ruiz, J; Vila, J1
Hostacká, A; Kováciková, Z2
Caballero, FJ; Cuberos, L; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ1
Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M1
Hsu, WM; Kao, SC; Kau, HC; Liu, JH; Tsai, CC1
Abrutyn, E; Egert, J; Goodhart, GL; Root, RK; Watson, R1
McGee, ZA; Meacham, WF; Oldfield, EH; Wirt, TC1
Bouvet, P; Buisson, Y; Driot, L; Ginot, L; Meyran, M; Schill, H; Tran Van Nhieu, G1
Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF1
Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K1

Reviews

1 review(s) available for amikacin and Acinetobacter Infections

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022

Trials

2 trial(s) available for amikacin and Acinetobacter Infections

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Journal of critical care, 2003, Volume: 18, Issue:2

    Topics: Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Area Under Curve; Creatinine; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Prospective Studies; Pseudomonas Infections; Superinfection

2003

Other Studies

73 other study(ies) available for amikacin and Acinetobacter Infections

ArticleYear
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Military Personnel; Minocycline; Polymyxin B; United States; Warfare

2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests

2007
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid

2007
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; North America; RNA, Ribosomal, 16S; Sequence Analysis, DNA

2007
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA

2007
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA

2008
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Endemic Diseases; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Sequence Analysis, DNA

2008
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids

2008
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction

2008
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans

2008
Detection of KPC in Acinetobacter spp. in Puerto Rico.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Puerto Rico

2010
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan

2010
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Hospitals, Special; Humans; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Young Adult

2021
Variants of Tn
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genome, Bacterial; Macrolides; Meropenem; Phylogeny; Sequence Alignment

2022
In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023, Volume: 54, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Immunoglobulins, Intravenous; Meropenem; Microbial Sensitivity Tests

2023
Amikacin resistance due to the aphA6 gene in multi-antibiotic resistant Acinetobacter baumannii isolates belonging to global clone 1 from Iran.
    BMC microbiology, 2019, 09-18, Volume: 19, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Iran; Kanamycin Kinase; Plasmids

2019
Amikacin-resistant Acinetobacter species mediated by the aphA6 gene associated with clinical outcome at an academic complex hospital in KwaZulu-Natal Province, South Africa.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019, Dec-12, Volume: 110, Issue:1

    Topics: Academic Medical Centers; Acid Phosphatase; Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; South Africa; Treatment Outcome; Young Adult

2019
Synergistic Effect of Tazobactam on Amikacin MIC in Acinetobacter baumannii Isolated from Burn Patients in Tehran, Iran.
    Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Drug Resistance, Multiple, Bacterial; Drug Synergism; Genes, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Tazobactam

2020
Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.
    Microbial pathogenesis, 2020, Volume: 149

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Immunoglobulins, Intravenous; Meropenem; Microbial Sensitivity Tests

2020
In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Colistin; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination

2021
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
    BMC infectious diseases, 2017, 07-06, Volume: 17, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Caenorhabditis elegans; Community-Acquired Infections; Cross Infection; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Virulence

2017
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand

2018
Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments.
    Scientific reports, 2018, 02-23, Volume: 8, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Ontology; High-Throughput Nucleotide Sequencing; Humans; Imipenem; Meropenem; Molecular Sequence Annotation; Transcriptome

2018
Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
    Recent patents on anti-infective drug discovery, 2018, Volume: 13, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Gold; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Patents as Topic; Wound Infection

2018
Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adenosine Triphosphate; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Membrane Potentials; Microbial Sensitivity Tests; Microbial Viability

2019
Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Microbial pathogenesis, 2019, Volume: 131

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Chalcones; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Virulence Factors

2019
Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Acetylation; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clioquinol; Drug Hypersensitivity; Drug Resistance, Microbial; Enzyme Inhibitors; HEK293 Cells; Humans; Zinc

2019
Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates.
    Clinical laboratory, 2019, 07-01, Volume: 65, Issue:7

    Topics: Acetyltransferases; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Nucleotidyltransferases; Phosphotransferases

2019
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin

2013
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline

2013
Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Critical Illness; Humans; Intensive Care Units; Microbial Sensitivity Tests; Models, Statistical; Plasma; Time Factors

2013
Acinetobacter baumannii infections in a tertiary care hospital in Mexico over the past 13 years.
    Chemotherapy, 2013, Volume: 59, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Intensive Care Units; Meropenem; Mexico; Microbial Sensitivity Tests; Tertiary Healthcare; Thienamycins

2013
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.
    American journal of infection control, 2014, Volume: 42, Issue:6

    Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors

2014
Amikacin resistance plasmids in extensively antibiotic-resistant GC2 Acinetobacter baumannii from two Australian hospitals.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Australia; Drug Resistance, Bacterial; Genes, Bacterial; Hospitals; Humans; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA

2014
Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Australia; Carbapenems; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Order; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA

2015
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
    The new microbiologica, 2015, Volume: 38, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline

2015
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins

2015
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries

2015
Outbreak of drug-resistant Acinetobacter baumannii ST219 caused by oral care using tap water from contaminated hand hygiene sinks as a reservoir.
    American journal of infection control, 2015, Volume: 43, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Bacterial; Emergency Service, Hospital; Genotype; Hand Hygiene; Hospitals, University; Humans; Infection Control; Intensive Care Units; Japan; Water Microbiology

2015
Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clone Cells; Drug Resistance, Bacterial; Gene Expression; Gene Frequency; Genotype; Gentamicins; Hospitals; Humans; Iran; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Netilmicin; Phenotype; Phylogeny; Tobramycin

2016
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin

2016
Intrathecal use of amikacin: a case report.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Craniotomy; Fatal Outcome; Humans; Injections, Spinal; Male; Meningitis, Bacterial; Subarachnoid Hemorrhage; Sulbactam

2008
Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
    Yonsei medical journal, 2011, Volume: 52, Issue:5

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea

2011
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:10

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline

2012
bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India.
    Journal of infection in developing countries, 2012, Nov-26, Volume: 6, Issue:11

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; India; Intensive Care Units; Meropenem; Phenotype; Polymerase Chain Reaction; Pseudomonas; Pseudomonas Infections; Thienamycins

2012
In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Sulbactam

2002
Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Male; Pneumonia, Bacterial; Protease Inhibitors

2003
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance

2003
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
    La Tunisie medicale, 2003, Volume: 81, Issue:2

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Morocco; Retrospective Studies

2003
Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Acetyltransferases; Acinetobacter; Acinetobacter Infections; Amikacin; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cloning, Molecular; Culture Media; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Humans; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction

2004
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Imipenem; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial

2005
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
    The Journal of infection, 2005, Volume: 51, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Infusions, Intravenous; Injections, Spinal; Male; Meningitis, Bacterial; Middle Aged; Treatment Failure

2005
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Yonsei medical journal, 2006, Feb-28, Volume: 47, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance

2006
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome

2007
[Intrathecal use of amikacin and colistin].
    Annales francaises d'anesthesie et de reanimation, 2008, Volume: 27, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Amikacin; Brain Ischemia; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocephalus; Injections, Spinal; Male; Meningitis, Bacterial; Pseudomonas Infections; Shock, Septic; Surgical Wound Infection; Ventriculostomy

2008
Acinetobacter spp. in gunshot injuries.
    Emerging infectious diseases, 2008, Volume: 14, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Timor-Leste; Wounds, Gunshot

2008
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Antagonism; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2008
A case of Acinetobacter calcoaceticus pneumonia.
    Thorax, 1995, Volume: 50, Issue:3

    Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Amikacin; Ceftriaxone; Community-Acquired Infections; Diagnosis, Differential; Humans; Male; Pneumonia, Bacterial

1995
Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.
    Neurosurgery, 1994, Volume: 35, Issue:5

    Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Brain Diseases; Brain Neoplasms; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Surgical Wound Infection

1994
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
    Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic

1997
Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Chromosomes, Bacterial; DNA, Bacterial; Drug Resistance, Microbial; Humans; Polymerase Chain Reaction; Spain

1999
Cytotoxic activity of Acinetobacter baumannii after treatment with aminoglycosides.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:9

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Cytotoxins; Epithelial Cells; Gentamicins; Male; Microbial Sensitivity Tests; Netilmicin; Pulmonary Alveoli; Rats; Rats, Wistar

1999
Effect of amikacin on cytotoxic activity and hydrophobicity of Acinetobacter baumannii.
    Methods and findings in experimental and clinical pharmacology, 1999, Volume: 21, Issue:10

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Cell Survival; Chemical Phenomena; Chemistry, Physical; Epithelial Cells; Male; Microbial Sensitivity Tests; Pulmonary Alveoli; Rats; Rats, Wistar; Respiratory System

1999
Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Survival Analysis; Thienamycins; Time Factors

2000
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5

    Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins

2000
Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii.
    Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:5

    Topics: Acinetobacter; Acinetobacter Infections; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Phacoemulsification; Surgical Wound Infection

2002
Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia.
    JAMA, 1977, Oct-03, Volume: 238, Issue:14

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Alcoholism; Amikacin; Diagnostic Errors; Drug Resistance, Microbial; Female; Gentamicins; Humans; Liver Cirrhosis; Male; Middle Aged; Minocycline; Pneumonia; Sputum; Staining and Labeling; Tobramycin

1977
Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Journal of neurosurgery, 1979, Volume: 50, Issue:1

    Topics: Acinetobacter Infections; Amikacin; Child, Preschool; Encephalitis; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Injections, Intraventricular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Serratia marcescens

1979
Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage.
    The Journal of hospital infection, 1990, Volume: 15, Issue:1

    Topics: Acinetobacter Infections; Amikacin; Bacteriophage Typing; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; France; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Retrospective Studies; Serotyping; Tobramycin

1990
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
    Pathologie-biologie, 1988, Volume: 36, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins

1988
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
    The Japanese journal of antibiotics, 1985, Volume: 38, Issue:8

    Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis

1985